Fibromyalgia – FDA approves Cyclobenzaprine

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets, a first-in-class, non-opioid treatment for adults with fibromyalgia, a chronic pain syndrome that affects more than 10 million Americans, roughly 80% of whom are women. The medication, taken once-daily at bedtime, targets nonrestorative sleep, a root cause of pain, fatigue, and brain fog in fibromyalgia. It’s the Read more

Virtual reality for stroke rehabilitation

Virtual reality (VR) applications have emerged as a treatment approach in stroke rehabilitation. Different types of studies have been used from non‐immersive, non‐customised, interactive game‐based applications to immersive applications specifically designed for rehabilitation settings. Objectives Primary objective: to assess the effects of VR compared with an alternative intervention or no Read more

Multivitamin Supplements Improve Memory and Slow Cognitive Aging in Older Adults

Background: Longer effects of multivitamin-mineral (MVM) supplementation on late-life cognitive function remain untested using in-person, detailed neuropsychological assessments. Furthermore, insufficient evidence exists for healthcare providers to recommend daily MVM supplements to prevent cognitive decline. The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) (Ref-1) at Brigham and Women’s Hospital, an affiliate Read more